Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Of Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein In Acute Gout

NCT05925166 is registered in ClinicalTrials.gov with Lihua Duan as lead sponsor.

NCT NCT05925166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05925166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Of Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein In Acute Gout
Lead sponsor
Lihua Duan
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2020
Completion date
January 31, 2026
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute gout